PATAS Trifluoroacetate

N/A

Report date: 2025/11/05 20:01:16
NME

Base Information

Drug NamePATAS Trifluoroacetate
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCentrosome-associated protein ALMS1 modulatorsProtein kinase C alpha modulators
TargetsCentrosome-associated protein ALMS1Protein kinase C alpha
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAdipoPharma LLC
China Registration ClassN/A

Develop Information

Active CompaniesAdipoPharma LLC
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A